234 devices · GMDN 60119
DNA-based tissue typing reagents are in vitro diagnostics used to analyze genetic markers in the major histocompatibility complex (MHC) to assess compatibility between tissue donors and recipients. These tests help predict transplant outcomes by identifying key genetic variations like HLA-A, HLA-B, or DQB1, reducing the risk of rejection in procedures such as organ or bone marrow transplants.
These reagents are typically classified as in vitro diagnostics and must comply with regulatory standards for genetic testing, though classification varies by jurisdiction. They are often supplied as part of a larger assay system and require validation for accuracy in clinical settings, ensuring reliable results for transplant planning.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.